APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation Tatsuo KandaGeorge K. K. LauMasao Omata Guidelines Open access 20 September 2019 Pages: 649 - 661
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease Mohammed EslamJacob George Editorial 04 October 2019 Pages: 662 - 664
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift Yun-Fan Liaw Review Article 26 September 2019 Pages: 665 - 673
Sarcopenia and fatty liver disease Jung A. KimKyung Mook Choi Review Article 08 November 2019 Pages: 674 - 687
Hepatocellular carcinoma and non-alcoholic fatty liver disease Pegah GolabiLogan RheaZobair M. Younossi Review Article 07 November 2019 Pages: 688 - 694
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region Tao ChenZhongyuan YangQin Ning Original Article 24 October 2019 Pages: 695 - 705
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents Hanaa A. El-ArabyBehairy E. BehairyBassam A. Ayoub Original Article 12 September 2019 Pages: 706 - 714
Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection Xiuming ZhangYanfeng BaiJimin Liu Original Article 17 September 2019 Pages: 715 - 725
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study Yeonjung HaTae Hun KimHan Chu Lee Original Article 05 November 2019 Pages: 726 - 735
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis Chao LiMing-Da WangTian Yang Original Article 05 September 2019 Pages: 736 - 747
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study Chikara IinoTetsu EndoShinsaku Fukuda Original Article 12 September 2019 Pages: 748 - 756
Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis Bin LiuYingrui LiQiang She Original Article 20 August 2019 Pages: 757 - 765
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis Qianyi WangHong YouJidong Jia Original Article 26 September 2019 Pages: 766 - 776
Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure Smriti ShubhamDhananjay KumarShiv Kumar Sarin Original Article 12 September 2019 Pages: 777 - 787
Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis Na ZengWeijia DuanJidong Jia Original Article 25 September 2019 Pages: 788 - 799
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial Manoj KumarSumit KainthShiv K. Sarin Original Article 20 September 2019 Pages: 800 - 813
MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis Shuang RenJiamei ChenPing Liu Original Article 23 October 2019 Pages: 814 - 825
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update Shiv Kumar SarinAshok ChoudhuryAPASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Correction Open access 09 October 2019 Pages: 826 - 828
